ES2055415T3 - S-adenosil-metionina para el tratamiento de pancreatitis y del inmunorechazo del trasplante de pancreas. - Google Patents

S-adenosil-metionina para el tratamiento de pancreatitis y del inmunorechazo del trasplante de pancreas.

Info

Publication number
ES2055415T3
ES2055415T3 ES90902247T ES90902247T ES2055415T3 ES 2055415 T3 ES2055415 T3 ES 2055415T3 ES 90902247 T ES90902247 T ES 90902247T ES 90902247 T ES90902247 T ES 90902247T ES 2055415 T3 ES2055415 T3 ES 2055415T3
Authority
ES
Spain
Prior art keywords
pancreatitis
treatment
pct
metionina
immunorechazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90902247T
Other languages
English (en)
Inventor
Ian V Hutchinson
Joan M Braganza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioresearch SRL
Original Assignee
Bioresearch SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch SRL filed Critical Bioresearch SRL
Application granted granted Critical
Publication of ES2055415T3 publication Critical patent/ES2055415T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

COMPOSICIONES TERAPEUTICAS COMPRENDIENDO S-ADENOSIL-METIONINA UTILES EN EL TRATAMIENTO DE LA PANCREATITIS Y COMO AGENTE SINERGISTICO DE LA CICLOSPORINA EN LA PREVENCION DEL RECHAZO DE INJERTOS EN EL TRANSPLANTE DE PANCREAS.
ES90902247T 1989-01-14 1990-01-10 S-adenosil-metionina para el tratamiento de pancreatitis y del inmunorechazo del trasplante de pancreas. Expired - Lifetime ES2055415T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898900812A GB8900812D0 (en) 1989-01-14 1989-01-14 Pharmaceutical method and compositions

Publications (1)

Publication Number Publication Date
ES2055415T3 true ES2055415T3 (es) 1994-08-16

Family

ID=10650037

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90902247T Expired - Lifetime ES2055415T3 (es) 1989-01-14 1990-01-10 S-adenosil-metionina para el tratamiento de pancreatitis y del inmunorechazo del trasplante de pancreas.

Country Status (15)

Country Link
US (1) US5196402A (es)
EP (1) EP0408711B1 (es)
JP (1) JPH03503289A (es)
KR (1) KR910700055A (es)
AT (1) ATE104551T1 (es)
AU (1) AU630159B2 (es)
CA (1) CA2026580A1 (es)
DE (1) DE69008258T2 (es)
DK (1) DK0408711T3 (es)
ES (1) ES2055415T3 (es)
GB (1) GB8900812D0 (es)
HU (1) HU206626B (es)
RU (1) RU2014837C1 (es)
WO (1) WO1990007928A1 (es)
ZA (1) ZA90241B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243859B (it) * 1990-10-23 1994-06-28 Bioresearch Spa Composizioni farmaceutiche comprendenti associazioni fra sali di s-adenosil-l-metionina e acido 5-metil (o 5-formil)-tetraidrofolico per la terapia di complicanze neurologiche negli ammalati di aids.
US6492349B1 (en) 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
US5508262A (en) * 1993-12-15 1996-04-16 University Of South Florida Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
US5747461A (en) * 1994-07-26 1998-05-05 Markov; Angel K. Synergistic administration of cyclosporine and fructose diphosphate
US5723116A (en) * 1995-01-06 1998-03-03 University Of South Florida Decreased mortality of severe acute pancreatitis following proximal cytokine blockade
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US6063600A (en) * 1997-05-23 2000-05-16 Uab Research Foundation DNA encoding canine interleukin-1 receptor antagonist
US6399093B1 (en) 1999-05-19 2002-06-04 Advanced Medical Instruments Method and composition to treat musculoskeletal disorders
US8168233B2 (en) * 2002-10-18 2012-05-01 Amylin Pharmaceuticals, Inc. Treatment of pancreatitis with amylin
US20050272687A1 (en) * 2004-06-08 2005-12-08 Hebert Rolland F Stable S-adenosyl-l-methionine
US20090075974A1 (en) * 2005-04-27 2009-03-19 Umn Pharma Inc. Agent for prophylaxis and treatment of pancreatitis
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
US9039962B2 (en) 2010-03-30 2015-05-26 Nippon Steel & Sumitomo Metal Corporation Steel for induction hardening, roughly shaped material for induction hardening, producing method thereof, and induction hardening steel part
EP2949331A1 (en) 2012-10-17 2015-12-02 Methylation Sciences International SRL Compositions comprising s-adenosylmethionine and a gallic acid ester
EP4712796A2 (en) 2023-05-15 2026-03-25 Bonafide Health, LLC Sleep-improving compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1169772B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
WO1989003389A1 (en) * 1987-10-09 1989-04-20 Vincenzo Zappia Lipophilic salts of s-adenosyl-l-methionine (sam) with acylated taurine derivatives

Also Published As

Publication number Publication date
DE69008258D1 (de) 1994-05-26
US5196402A (en) 1993-03-23
HU206626B (en) 1992-12-28
HUT54893A (en) 1991-04-29
WO1990007928A1 (en) 1990-07-26
GB8900812D0 (en) 1989-03-08
CA2026580A1 (en) 1990-07-15
KR910700055A (ko) 1991-03-13
EP0408711B1 (en) 1994-04-20
JPH03503289A (ja) 1991-07-25
ATE104551T1 (de) 1994-05-15
EP0408711A1 (en) 1991-01-23
DE69008258T2 (de) 1994-08-04
DK0408711T3 (da) 1994-06-06
AU5026090A (en) 1990-08-13
AU630159B2 (en) 1992-10-22
HU901516D0 (en) 1991-03-28
RU2014837C1 (ru) 1994-06-30
ZA90241B (en) 1991-03-27

Similar Documents

Publication Publication Date Title
HUT54893A (en) Use of 5-adenosylmethionine for treating pancreatitis and for preventing rejection of transplanted pancreas
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
MX173183B (es) Uso de la rapamicina para la preparacion de una composicion para inhibir el rechazo de transplantes de organos o tejidos en un mamifero que lo necesita
HUT55607A (en) Bacteriocin compositions with improved activity and wide spectrum utilizable as bactericides and methods for preventing and treating microbial infections
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
FR2786664B1 (fr) Procede de traitement de fruits et legumes utilisant l'eugenol et/ou l'isoeugenol et utilisation d'une composition a base d'eugenol et/ou d'isoeugenol
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
ES2195325T3 (es) Procedimiento y formulacion que contiene enzimas para descomponer desperdicios de alimentos.
DE69310528D1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DE69803773D1 (de) Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion
DK0914078T3 (da) Anvendelse af L-lysin til behandling af hårtab
DE69526584D1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
ES2183814T3 (es) Composicion farmaceutica que contiene il-6 y su uso para el tratamiento del trastorno trombohemorragico de consumo.
DE69023006D1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
NZ237739A (en) Pharmaceutical composition of a complement inhibitor and an immunosuppressant with cyclosporin a-like activity, and its use
DE69006360D1 (de) L-alpha-glycerophosphoryl-d-myoinositol zur behandlung peripherer neuropathien und cerebropathien.
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
DE69426986D1 (de) Behandlung von laminitis
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund
ES2025787T3 (es) Procedimiento de tratamiento de madera.
DE3570829D1 (en) A synergistic admixture containing "-bromo-2-bromomethylglutaronitrile and methylene bis (thiocyanate) and process for inhibiting microbial growth using said components

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 408711

Country of ref document: ES